Clinical Trial Update: Prevention of Arteriovenous Thrombotic Events in Critically-Ill COVID-19 Patients Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update on prevention of arteriovenous thrombotic events in critically ill COVID-19 patients; trial completed with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Arterial Thrombosis
• Venous Thromboembolism

Snippet

Sponsor: The TIMI Study Group | Conditions: COVID-19, Venous Thromboembolism | Phase 4 | Status: COMPLETED | Results posted: 2024-01-19